• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.

作者信息

Salah Husam M, Naser Jwan A, Calcaterra Giuseppe, Bassareo Pier Paolo, Mehta Jawahar L

机构信息

Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

出版信息

Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.

DOI:10.1016/j.amjcard.2020.08.005
PMID:32892991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7428681/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc0/7428681/37363cc262d3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc0/7428681/adf9dc0339a8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc0/7428681/37363cc262d3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc0/7428681/adf9dc0339a8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc0/7428681/37363cc262d3/gr2_lrg.jpg

相似文献

1
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。
Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.
2
2020 - Year of COVID-19.2020年——新冠疫情之年。
J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041.
3
Anticoagulation in COVID-19: DDI Perspective.COVID-19中的抗凝治疗：药物相互作用视角
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620959457. doi: 10.1177/1076029620959457.
4
ISTH DIC subcommittee communication on anticoagulation in COVID-19.ISTH DIC 小组委员会关于 COVID-19 抗凝治疗的沟通。
J Thromb Haemost. 2020 Sep;18(9):2138-2144. doi: 10.1111/jth.15004.
5
COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
6
COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.新型冠状病毒肺炎凝血功能障碍与炎症：已知与未知
Anesth Analg. 2020 Nov;131(5):1323. doi: 10.1213/ANE.0000000000005215.
7
Meta-Analysis of Relation of Creatine kinase-MB to Risk of Mortality in Coronavirus Disease 2019 Patients.2019冠状病毒病患者肌酸激酶同工酶与死亡风险关系的Meta分析
Am J Cardiol. 2020 Sep 1;130:163-165. doi: 10.1016/j.amjcard.2020.06.004. Epub 2020 Jun 10.
8
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.肾素-血管紧张素-醛固酮系统抑制剂治疗高血压患者可降低COVID-19死亡率：一项荟萃分析
Hypertension. 2020 Aug;76(2):e13-e14. doi: 10.1161/HYPERTENSIONAHA.120.15572. Epub 2020 May 27.
9
Lessons from the Italian COVID-19 frontline.来自意大利新冠疫情前线的经验教训。
Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1.
10
Cobrotoxin could be an effective therapeutic for COVID-19.眼镜蛇毒素可能是治疗新冠肺炎的一种有效疗法。
Acta Pharmacol Sin. 2020 Sep;41(9):1258-1260. doi: 10.1038/s41401-020-00501-7. Epub 2020 Aug 25.

引用本文的文献

1
Management of Patients With COVID-19 During the Pandemic: A Retrospective Cohort Study From a Tertiary Care Centre in Mumbai, India.疫情期间新冠病毒病患者的管理：来自印度孟买一家三级医疗中心的回顾性队列研究
Cureus. 2025 May 8;17(5):e83711. doi: 10.7759/cureus.83711. eCollection 2025 May.
2
Severely Ill COVID-19 Patients May Exhibit Hypercoagulability Despite Escalated Anticoagulation.尽管加强了抗凝治疗，但重症 COVID-19 患者仍可能出现高凝状态。
J Clin Med. 2025 Mar 14;14(6):1966. doi: 10.3390/jcm14061966.
3
Mutual Inhibition of Antithrombin III and SARS-CoV-2 Cellular Attachment to Syndecans: Implications for COVID-19 Treatment and Vaccination.

本文引用的文献

1
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.SARS-CoV-2 感染依赖于细胞表面的肝素硫酸和 ACE2。
Cell. 2020 Nov 12;183(4):1043-1057.e15. doi: 10.1016/j.cell.2020.09.033. Epub 2020 Sep 14.
2
Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital.伦敦市中心一家教学医院收治的新冠肺炎成年住院患者的临床特征及28天死亡率
J Infect. 2020 Sep;81(3):e85-e89. doi: 10.1016/j.jinf.2020.06.027. Epub 2020 Jun 18.
3
Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.
抗凝血酶 III 与 SARS-CoV-2 细胞附着到 syndecans 的相互抑制：对 COVID-19 治疗和疫苗接种的影响。
Int J Mol Sci. 2024 Jul 9;25(14):7534. doi: 10.3390/ijms25147534.
4
Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data.**药物处方模式及其与 COVID-19 患者死亡率和住院时间的关系：大数据洞察。**
Front Public Health. 2023 Dec 18;11:1280434. doi: 10.3389/fpubh.2023.1280434. eCollection 2023.
5
Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19.评估 COVID-19 住院患者的抗凝肝素类似物剂量水平对医疗资源的利用情况。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221137848. doi: 10.1177/10760296221137848.
6
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.通过病毒基因组学和结构分析探讨严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的发病机制、症状学及传播途径
mSystems. 2021 Oct 26;6(5):e0009521. doi: 10.1128/mSystems.00095-21.
7
Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death.肺间质扩张和肺泡内凝血是新冠病毒病死亡的主要原因。
Heliyon. 2021 May;7(5):e07134. doi: 10.1016/j.heliyon.2021.e07134. Epub 2021 May 24.
8
Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis.荷兰实验室确诊 COVID-19 患者住院期间死亡的危险因素：竞争风险生存分析。
PLoS One. 2021 Mar 26;16(3):e0249231. doi: 10.1371/journal.pone.0249231. eCollection 2021.
9
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.通过病毒基因组学和结构分析探讨严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的发病机制、症状学及传播途径
ArXiv. 2021 Feb 1:arXiv:2102.01521v4.
10
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.美国住院患者预防性抗凝治疗对预防2019冠状病毒病死亡的早期启动：队列研究
BMJ. 2021 Feb 11;372:n311. doi: 10.1136/bmj.n311.
中国武汉新冠肺炎住院患者的临床特征及死亡风险因素
Clin Transl Med. 2020 Jun;10(2):e40. doi: 10.1002/ctm2.40. Epub 2020 Jun 4.
4
The association between treatment with heparin and survival in patients with Covid-19.肝素治疗与 COVID-19 患者生存之间的关联。
J Thromb Thrombolysis. 2020 Aug;50(2):298-301. doi: 10.1007/s11239-020-02162-z.
5
COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?新冠病毒感染相关的高黏滞血症：炎症与血栓形成倾向之间的联系？
Lancet. 2020 Jun 6;395(10239):1758-1759. doi: 10.1016/S0140-6736(20)31209-5. Epub 2020 May 25.
6
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.COVID-19 患者在意大利疫情第一波期间住院治疗的 30 天死亡率：一项前瞻性队列研究。
Pharmacol Res. 2020 Aug;158:104931. doi: 10.1016/j.phrs.2020.104931. Epub 2020 May 22.
7
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
8
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
9
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.新型冠状病毒病 2019 感染相关静脉血栓栓塞症的预防与治疗：指南出台前的共识声明。
Thromb Haemost. 2020 Jun;120(6):937-948. doi: 10.1055/s-0040-1710019. Epub 2020 Apr 21.
10
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.